BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 6873013)

  • 1. The role of growth of normal and preneoplastic cell populations for tumor promotion in rat liver.
    Schulte-Hermann R; Schuppler J; Timmermann-Trosiener I; Ohde G; Bursch W; Berger H
    Environ Health Perspect; 1983 Apr; 50():185-94. PubMed ID: 6873013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin.
    Schulte-Hermann R; Ohde G; Schuppler J; Timmermann-Trosiener I
    Cancer Res; 1981 Jun; 41(6):2556-62. PubMed ID: 6165465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds.
    Schulte-Hermann R; Timmermann-Trosiener I; Schuppler J
    Cancer Res; 1983 Feb; 43(2):839-44. PubMed ID: 6848197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters.
    Bursch W; Lauer B; Timmermann-Trosiener I; Barthel G; Schuppler J; Schulte-Hermann R
    Carcinogenesis; 1984 Apr; 5(4):453-8. PubMed ID: 6231134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of liver foci in rats to hepatic tumor promoters.
    Schulte-Hermann R; Timmermann-Trosiener I; Schuppler J
    Toxicol Pathol; 1982 Feb; 10(2):63-68. PubMed ID: 28094714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
    Gerbracht U; Bursch W; Kraus P; Putz B; Reinacher M; Timmermann-Trosiener I; Schulte-Hermann R
    Carcinogenesis; 1990 Apr; 11(4):617-24. PubMed ID: 1691053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell proliferation and apoptosis in normal liver and preneoplastic foci.
    Schulte-Hermann R; Bursch W; Kraupp-Grasl B; Oberhammer F; Wagner A; Jirtle R
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):87-90. PubMed ID: 8013429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
    Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
    Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response studies on the effects of alpha-, beta-, and gamma-hexachlorocyclohexane on putative preneoplastic foci, monooxygenases, and growth in rat liver.
    Schröter C; Parzefall W; Schröter H; Schulte-Hermann R
    Cancer Res; 1987 Jan; 47(1):80-8. PubMed ID: 2431769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term phenobarbital administration does not promote the multiplication of hepatocytes replicating after single cyproterone acetate administration.
    Pichard V; Ferry N
    Life Sci; 2005 May; 76(26):3057-68. PubMed ID: 15850598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell proliferation and regulation of negative growth factors in mouse liver foci.
    Moser GJ; Wolf DC; Harden R; Standeven AM; Mills J; Jirtle RL; Goldsworthy TL
    Carcinogenesis; 1996 Sep; 17(9):1835-40. PubMed ID: 8824503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation.
    Melnick RL; Huff J
    Toxicol Ind Health; 1993; 9(3):415-38. PubMed ID: 8367884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative aspects of chemical carcinogenesis and tumor promotion in liver.
    Kunz HW; Tennekes HA; Port RE; Schwartz M; Lorke D; Schaude G
    Environ Health Perspect; 1983 Apr; 50():113-22. PubMed ID: 6223810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An origin of presumptive preneoplastic foci and nodules from hepatocytes in chemical carcinogenesis in rat liver.
    Gindi T; Ghazarian DM; Deitch D; Farber E
    Cancer Lett; 1994 Aug; 83(1-2):75-80. PubMed ID: 8062236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent proliferation of normal hepatocytes and promotion of preneoplastic development by N-nitrosodibenzylamine in rats.
    Blaszyk H; Hartmann A; Danz M
    J Cancer Res Clin Oncol; 1993; 120(1-2):71-5. PubMed ID: 8270612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin.
    Grasl-Kraupp B; Huber W; Timmermann-Trosiener I; Schulte-Hermann R
    Carcinogenesis; 1993 Nov; 14(11):2435-7. PubMed ID: 8242878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 2,3,7,8-tetrachloro- and 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin on the proliferation of preneoplastic liver cells in the rat.
    Buchmann A; Stinchcombe S; Körner W; Hagenmaier H; Bock KW
    Carcinogenesis; 1994 Jun; 15(6):1143-50. PubMed ID: 8020147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis.
    Pascale RM; Simile MM; Satta G; Seddaiu MA; Daino L; Pinna G; Vinci MA; Gaspa L; Feo F
    Anticancer Res; 1991; 11(4):1617-24. PubMed ID: 1684097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression.
    Grasl-Kraupp B; Ruttkay-Nedecky B; Müllauer L; Taper H; Huber W; Bursch W; Schulte-Hermann R
    Hepatology; 1997 Apr; 25(4):906-12. PubMed ID: 9096596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.